Invitation to presentation of Isofol´s report for the second quarter of 2022
GOTHENBURG, Sweden, August 15, 2022 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) (“Isofol”), will publish the company’s results for […]
Other Corporate Information
Isofol Announces Topline Results of Phase III AGENT Study – Did Not Meet Primary or Key Secondary Endpoints
GOTHENBURG, Sweden, August 3, 2022 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), today announced topline results that neither the
Isofol receives approval of biomarker analysis patent and intention-to-grant patent application for study dose regimen in Europe
GOTHENBURG, Sweden, July 26, 2022 – Isofol Medical AB (http://isofol.se/en/) (publ) (Nasdaq Stockholm: ISOFOL), today announced the European approval for a
Isofol updates start time of live-streamed R&D event on June 20 to 14:00 CEST
GOTHENBURG, Sweden, June 17, 2022 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), announced today that the company is postponing
Isofol invites to a live-streamed R&D Event on June 20 at 12.30 CEST
GOTHENBURG, Sweden, June 14, 2022 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), announced today that the company invites investors,
Invitation to presentation of Isofol’s report for the first quarter of 2022
GOTHENBURG, Sweden, May 3, 2022 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) (“Isofol”), will publish the company’s results for
Isofol announces start of study data analysis of phase III AGENT study in advanced metastatic colorectal cancer
GOTHENBURG, Sweden, April 22, 2022 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), today announced the start of data analysis
Invitation to presentation of Isofol’s year-end report 2021 on February 24, 2022
GOTHENBURG, Sweden, February 14, 2022 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) (“Isofol”), will publish the company’s year-end report
Isofol recognizes World Cancer Day on February 4
Today, February 4, is World Cancer Day (https://www.worldcancerday.org/), and we at Isofol are sending our thoughts to those affected by advanced
Isofol Medical AB (publ) invites to an audiocast on December 6 at 08.00 a.m. CET
GOTHENBURG, Sweden, December 5, 2021 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), announced on December 3 that the ongoing